Sleep therapy may stop menopause depression before it starts
NCT ID NCT07443644
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a digital insomnia treatment (dCBT-I) can prevent depression in perimenopausal women with sleep problems. 230 women will receive either dCBT-I or sleep hygiene education and be followed for 2 years. The goal is to see if improving sleep reduces depressive symptoms.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
digital cognitive behavioral therapy for insomnia (dCBT-I)
What this could lead to
If it works, this could offer a non-drug way to prevent depression during menopause by treating insomnia early.
What could go wrong
This trial hasn't started yet, so results are uncertain. The intervention is behavioral, not a drug, and may not work for everyone. Also, it excludes women with current major depression.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INSOMNIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.